Menu

The latest from Magnitude Biosciences

A fully-fledged pre-clinical contract services provider. 
Here’s what we’ve been up to along the way!

16 April 2021
Magnitude Biosciences secures its second round of funding to support its pre-clinical research services

Magnitude Biosciences secures its second round of funding to support its pre-clinical research services

Read More
16 April 2021
Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, Paris.

Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, Paris.

Read More
7 April 2021
Magnitude Biosciences announces new hires to support continued growth

Durham, UK - March 2021 Magnitude Biosciences, a spin-out from Durham University and the leading contract lab services provider in using the nematode worm C. elegans to accelerate drug discovery and other research in the areas of the gut microbiome, ageing, and neurodegeneration, today announced the addition of two members to its growing team: Mira […]

Read More
5 March 2021
Magnitude Biosciences secures UK government Future Fund to expand its workforce.

Durham, UK - August 2020 Research into new medicines is needed more than ever, but research labs across the world are slowing down because of COVID-19 restrictions. Many companies and universities are turning increasingly to contract research organisations (CROs) to outsource their research. To meet this need, Magnitude Biosciences, a specialist CRO in CountyDurham, has […]

Read More
5 March 2021
Magnitude Biosciences' new COVID-19 compatible laboratory is fully operational and we are ready to support your research

Magnitude Biosciences moves its unique COVID-19 compatibletechnology to a new lab at NETPark in Sedgefield, County DurhamDurham, UK – May 2020 Specialist C. elegans CRO Magnitude Biosciences has completed the transfer of itsoperational facilities from Durham University to NETPark in Sedgefield. Following theacquisition of transgenic services provider Invermis, this move allows MagnitudeBiosciences to deliver its […]

Read More
5 March 2021
Magnitude Biosciences will be presenting at the online European Worm Meeting.

Magnitude Biosciences will be presenting at the online European Worm Meeting.

Read More
Magnitude Biosciences secures its second round of funding to support its pre-clinical research services
Magnitude Biosciences secures its second round of funding to support its pre-clinical research servi...Read More
Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, Paris.
Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, P...Read More
Magnitude Biosciences announces new hires to support continued growth
Durham, UK - March 2021 Magnitude Biosciences, a spin-out from Durham University and the leading con...Read More
Magnitude Biosciences secures UK government Future Fund to expand its workforce.
Durham, UK - August 2020 Research into new medicines is needed more than ever, but research labs acr...Read More
Magnitude Biosciences' new COVID-19 compatible laboratory is fully operational and we are ready to support your research
Magnitude Biosciences moves its unique COVID-19 compatibletechnology to a new lab at NETPark in Sedg...Read More
Magnitude Biosciences will be presenting at the online European Worm Meeting.
Magnitude Biosciences will be presenting at the online European Worm Meeting....Read More
Magnitude Biosciences now offers Transgenic Services after acquiring Invermis Ltd.
Magnitude Biosciences now offers Transgenic Services after acquiring Invermis Ltd. ...Read More
Magnitude Biosciences enters the world of Contract Research Services, as a spin-out from Durham University, UK
Magnitude Biosciences enters the world of Contract Research Services, as a spin-out from Durham Univ...Read More
Magnitude Biosciences secures its second round of funding to support its pre-clinical research services
Magnitude Biosciences secures its second round of funding to support its pre-clinical research servi...Read More
Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, Paris.
Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, P...Read More
Magnitude Biosciences announces new hires to support continued growth
Durham, UK - March 2021 Magnitude Biosciences, a spin-out from Durham University and the leading con...Read More
Magnitude Biosciences secures UK government Future Fund to expand its workforce.
Durham, UK - August 2020 Research into new medicines is needed more than ever, but research labs acr...Read More
Magnitude Biosciences' new COVID-19 compatible laboratory is fully operational and we are ready to support your research
Magnitude Biosciences moves its unique COVID-19 compatibletechnology to a new lab at NETPark in Sedg...Read More
Magnitude Biosciences will be presenting at the online European Worm Meeting.
Magnitude Biosciences will be presenting at the online European Worm Meeting....Read More
Magnitude Biosciences now offers Transgenic Services after acquiring Invermis Ltd.
Magnitude Biosciences now offers Transgenic Services after acquiring Invermis Ltd. ...Read More
Magnitude Biosciences enters the world of Contract Research Services, as a spin-out from Durham University, UK
Magnitude Biosciences enters the world of Contract Research Services, as a spin-out from Durham Univ...Read More

CONTACT US

Get in touch today to find out how we can 
support you to accelerate your research

CONTACT US

Get in touch today to find out how we can 
support you to accelerate your research
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram